Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Treating pseudomyxoma peritonei without heated intraperitoneal chemotherapy--a first look in New Zealand.

Wheeler BR, Reddy SK, Kenwright D, Keating JP.

N Z Med J. 2014 Feb 14;127(1389):31-9.

PMID:
24548955
2.

Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M.

Ann Surg Oncol. 2008 Feb;15(2):526-34. Epub 2007 Nov 28.

PMID:
18043976
3.

Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.

Vaira M, Cioppa T, DE Marco G, Bing C, D'Amico S, D'Alessandro M, Fiorentini G, DE Simone M.

In Vivo. 2009 Jul-Aug;23(4):639-44.

5.

Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei.

Sørensen O, Flatmark K, Reed W, Wiig JN, Dueland S, Giercksky KE, Larsen SG.

Eur J Surg Oncol. 2012 Oct;38(10):969-76. doi: 10.1016/j.ejso.2012.06.552. Epub 2012 Jul 3.

PMID:
22763244
6.

Pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic chemotherapy: a 7-year single-center experience.

Virzì S, Iusco D, Bonomi S, Grassi A.

Tumori. 2012 Sep-Oct;98(5):588-93. doi: 10.1700/1190.13199.

7.

Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gómez Portilla A, de Hingh IH, Ceelen WP, Pelz JO, Piso P, González-Moreno S, Van Der Speeten K, Morris DL.

J Clin Oncol. 2012 Jul 10;30(20):2449-56. doi: 10.1200/JCO.2011.39.7166. Epub 2012 May 21.

8.

Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomyxoma peritonei.

Cioppa T, Vaira M, Bing C, D'Amico S, Bruscino A, De Simone M.

World J Gastroenterol. 2008 Nov 28;14(44):6817-23.

9.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience.

Iversen LH, Rasmussen PC, Hagemann-Madsen R, Laurberg S.

Colorectal Dis. 2013 Jul;15(7):e365-72. doi: 10.1111/codi.12185.

PMID:
23458368
10.

Feasibility of peritonectomy associated with intraperitoneal hyperthermic perfusion in patients with Pseudomyxoma peritonei.

Deraco M, Gronchi A, Mazzaferro V, Inglese MG, Pennacchioli E, Kusamura S, Rizzi M, Anselmi RA Jr, Vaglini M.

Tumori. 2002 Sep-Oct;88(5):370-5.

PMID:
12487553
11.

Outcome of patients with aggressive pseudomyxoma peritonei treated by cytoreductive surgery and intraperitoneal chemotherapy.

Arjona-Sanchez A, Muñoz-Casares FC, Casado-Adam A, Sánchez-Hidalgo JM, Ayllon Teran MD, Orti-Rodriguez R, Padial-Aguado AC, Medina-Fernández J, Ortega-Salas R, Pulido-Cortijo G, Gómez-España A, Rufián-Peña S.

World J Surg. 2013 Jun;37(6):1263-70. doi: 10.1007/s00268-013-2000-2.

PMID:
23532601
12.
13.

Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved.

Dayal S, Taflampas P, Riss S, Chandrakumaran K, Cecil TD, Mohamed F, Moran BJ.

Dis Colon Rectum. 2013 Dec;56(12):1366-72. doi: 10.1097/DCR.0b013e3182a62b0d.

PMID:
24201390
14.

Outcome differences between debulking surgery and cytoreductive surgery in patients with Pseudomyxoma peritonei.

Andréasson H, Graf W, Nygren P, Glimelius B, Mahteme H.

Eur J Surg Oncol. 2012 Oct;38(10):962-8. doi: 10.1016/j.ejso.2012.07.009. Epub 2012 Jul 17.

PMID:
22809859
15.

Pseudomyxoma peritonei treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: results from a single centre.

Arjona-Sánchez Á, Muñoz-Casares FC, Rufián-Peña S, Díaz-Nieto R, Casado-Adam Á, Rubio-Pérez MJ, Ortega-Salas R.

Clin Transl Oncol. 2011 Apr;13(4):261-7. doi: 10.1007/s12094-011-0651-8.

PMID:
21493187
16.

Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin.

Järvinen P, Ristimäki A, Kantonen J, Lepistö A.

Scand J Surg. 2013;102(3):145-51. doi: 10.1177/1457496913490463.

PMID:
23963027
17.
18.

Comparative analysis of perioperative intraperitoneal chemotherapy regimen in appendiceal and colorectal peritoneal carcinomatosis.

Chua TC, Liauw W, Zhao J, Morris DL.

Int J Clin Oncol. 2013 Jun;18(3):439-46. doi: 10.1007/s10147-012-0397-5. Epub 2012 Mar 14.

PMID:
22415741
19.

Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei.

Güner Z, Schmidt U, Dahlke MH, Schlitt HJ, Klempnauer J, Piso P.

Int J Colorectal Dis. 2005 Mar;20(2):155-60. Epub 2004 Oct 16.

PMID:
15503065
20.

Cytoreductive surgery with intraperitoneal chemotherapy to treat pseudomyxoma peritonei at nonspecialized hospitals.

Kitai T, Kawashima M, Yamanaka K, Ichijima K, Fujii H, Mashima S, Shimahara Y.

Surg Today. 2011 Sep;41(9):1219-23. doi: 10.1007/s00595-010-4495-6. Epub 2011 Aug 26.

PMID:
21874418
Items per page

Supplemental Content

Write to the Help Desk